An urgent plea is spreading rapidly throughout the community, not just the voice of one mother, but the echo of thousands of families facing life-threatening cancers with few treatment options left.
She was not asking for pity.
She wasn’t looking for a miracle.
She is looking for an opportunity.
An opportunity that science once grasped, but then left behind for reasons no one can clearly explain.
In a moving message, this mother appealed to everyone to share their story.
She believed that among millions of followers, there might be “one person”—an individual with sufficient financial resources, vision, and courage to invest in a direction that major pharmaceutical corporations had abandoned.
It’s not because it lacks potential.
Maybe it’s because it’s too difficult.
Or it’s too new.
Or simply, it’s not suitable for quick profit calculations.
“The people who make the greatest impact are those who dare to choose the difficult path when others choose the easy one,” she wrote.
And then, she began to speak as clearly as possible about what she believed to be hope.
One therapy is called DeltaRex-G.
Formerly known as Rexin-G.
It’s not an unproven idea.
This is not just a hypothesis on paper.
This is a method that has undergone real-world clinical trials.
And in those tests, it showed positive results.
This is especially true for the most aggressive and difficult-to-treat types of cancer.
Bone cancer: osteosarcoma.
U not glioblastoma.
Pancreatic cancer.
Late-stage metastatic sarcoma.
These are all diseases where, once they’ve progressed to a certain stage, families are left with almost no other options.
There are no new treatment protocols.
There is no longer any clear hope.
The countdown is on.
This therapy was developed by a biotechnology company called Epeius Biotechnologies.
In its early years, it was seen as a promising direction.
But then in 2010, everything suddenly came to a halt.
It’s not a safety issue.
It’s not because of treatment failure.
But for “undisclosed reasons.”
The company retains ownership of the patent.
And they did not allow any other organization to continue further research or development.
For more than a decade afterward, this therapy was virtually frozen.
No progress.
Cannot be expanded.
Access is prohibited.
It exists only as an unfinished possibility.
Until 2021.
When patents expire.
The door, which seemed to have been locked shut, finally opened.
But a new problem arose.
No major pharmaceutical company stepped forward to continue.
There was no significant funding.
There was no large-scale development campaign.
No one was willing to embark on such a difficult and costly path.
So who is doing that?
A non-profit organization called the Aveni Foundation.
Under the guidance of Dr. Erlinda Gordon.
In collaboration with Dr. Sant Chawla – a world-leading expert on sarcoma.
They don’t have the resources that large corporations do.
But they have faith in science.
They have data from previous experiments.
And they are determined to continue.
Currently, some patients are being treated with this therapy.
It’s not that it’s ineffective, but rather that the quantity is small.
But because access is extremely limited.
Cost is the biggest barrier.
To produce one batch of the drug, approximately $500,000 is needed.
One such batch can treat four patients for a year.
Or 8 patients over 6 months.
The production process also takes many months.
And for terminally ill patients, “many months” is a luxury.
The mother in this story understands that very well.
Her son, Will, is battling illness every day.
Every hour that passes is meaningful.
Every decision can be a turning point.
She couldn’t sit still.
She sent emails to representatives from the state of Alabama.
Sent to the U.S. Food and Drug Administration (FDA).
Sent to the National Institutes of Health (NIH).
Sent to the National Cancer Institute (NCI).
To the Senators.
It was even sent to the U.S. Department of Health and Human Services.
And for the first time, she felt her voice had been heard.
An NIH director contacted Dr. Gordon directly.
Request more information about this therapy.
Based solely on the emails she sent.
That proves one thing.
That this is not impossible.
It just hasn’t been promoted strongly enough yet.
So today, she’s not just calling for sharing.
She was calling for something bigger.
If any billionaire were to donate to charity.
Or anyone who has a connection with them.
Those who are not seeking quick profits.
An easy victory isn’t necessary.
But I want to be a part of something challenging but meaningful.
Then please contact Dr. Erlinda Gordon.
Because this is a non-profit organization.
Not controlled by large pharmaceutical corporations.
This is a science that has previously shown potential.
And I’m waiting for someone I trust enough to continue the journey.
Meanwhile, the mother is still racing against time.
She is trying to gather Will’s medical records and genetic test results.
To see if your child is eligible for treatment.
If conditions permit, Dr. Gordon is ready to prepare a new batch of the medication.
But the condition is that there must be funding.
That’s a considerable number.
However, she made one thing clear.
She did not ask anyone to pay for her child’s treatment.
If necessary, she will raise funds herself.
She will find a way.
She always succeeds.
But this story isn’t just about Will.
It’s much bigger than that.
It’s about other kids.
Children don’t have time to wait for “perfect conditions.”
We can’t wait for business processes that take years to complete.
We can’t wait until things become “favorable”.
Because illness waits for no one.
And time cannot be turned back.
The mother insisted she wouldn’t stop.
She will continue to speak out.
Keep sharing.
Keep looking for opportunities.
She urged people to tag anyone who might be able to help.
Share this story.
Bring it before the eyes of those who have the power to create change.
Because “too difficult” should never be a reason to give up on something that has the potential to save lives.
Amidst all that tension, her and Will’s daily lives continued in their own unique way.
There were no spotlights.
There were no glamorous moments.
Only long, silent hours.
There are times when it seems endless.
In another post, she recounted a night that lasted sixteen hours straight.
The mother and daughter hardly moved from their positions.
There is no TV.
There is no sunlight.
There was no external interaction.
There was only silence.
And the little questions were repeated over and over again.
“Are you okay?”
Every twenty minutes, she would whisper like that.
She thought she could take advantage of the morning to go to church.
It’s only half a mile from home.
So close that it’s visible from a distance.
But when Will opened his eyes, the first thing he said was:
“Mom… do you go to church?”
Just a simple question.
But it was enough for her to understand everything.
She replied, “If you want me to stay, I will stay.”
And Will simply said, “Yes.”
A short word.
But it was enough to keep her there.
Like an invisible key.
Stronger than anything else.
She was there.
Next to my child.
I was afraid that if I pulled back the curtains to see the sunlight outside, my eyes wouldn’t be able to handle it because it had been so long since I’d seen sunlight.
It got to the point where even a minute in the bathroom became a luxury.
She couldn’t make it to church that day.
But she believed that God knew exactly where she was.
Because she had been talking to Him for sixteen hours straight.
Never stop.
Amidst the anxieties.
In the midst of moments of silence.
Between checking the baby’s breathing.
And at that moment, she understood one thing very clearly.
That’s exactly where she needs to be.
Next to my son.
On the simple sofa.
In a war nobody wanted.
But it was unavoidable.
Her story is more than just a call to action.
It’s a reminder.
That behind every medical breakthrough are real people.
Real families.
Real dreams.
And sometimes, all it takes is one person to believe.
A person who dares to invest in something difficult.
It could also change the fate of many other people.
